OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Idiopathic Pulmonary Fibrosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,832 reports · 47 co-occurring drugs

As of the last recalculation, Idiopathic Pulmonary Fibrosis appears in 3,832 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is NINTEDANIB (PRR 812.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Nintedanib2,111812.9871.9
Pirfenidone54384.285.4
0Xygen17319.920.0
Oxygen17319.920.0
Acetylcysteine2615.115.1
Tamsulosin Hydrochloride4411.811.9
Nebivolol217.27.2
Benzonatate216.96.9
Candesartan416.36.3
Ipratropium Bromide385.85.8
Ranolazine115.75.7
Doxepin105.45.4
Alendronate Sodium Tablet185.35.3
Selexipag255.35.3
Treprostinil1175.25.2
Loperamide Hydrochloride415.05.0
Pemetrexed194.84.8
Valsartan Oral474.74.7
Sildenafil Powder,304.64.6
Sotalol Hydrochloride144.64.6
Sildenafil484.54.5
Tiotropium Bromide Inhalation Spray94.44.4
Doxepin Hydrochloride104.34.3
Loperamide Hydrochloride And Dimethicone254.34.3
Simvastatin1814.14.1
Felodipine Extended-Release Tablets83.83.8
Felodipine83.83.8
Pemetrexed Disodium263.73.7
Pitavastatin Calcium73.73.7
Budesonide, Glycopyrrolate, And Formoterol Fumarate73.63.6
Macitentan453.63.6
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin133.43.4
Naproxen Sodium, Pseudoephedrine Hydrochloride133.43.4
Ivacaftor53.43.4
Nebivolol Hydrochloride213.43.4
Guaifenesin183.23.2
Glimepiride223.13.1
Dapagliflozin172.92.9
Sildenafil Citrate662.82.8
Tadalafil512.82.8
Bosentan252.72.7
Dronedarone52.72.7
Ambrisentan602.62.6
Dofetilide52.62.6
Umeclidinium Bromide And Vilanterol Trifenatate62.02.0
Apalutamide31.41.4
Dornase Alfa51.41.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.